351 related articles for article (PubMed ID: 18784461)
1. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.
Thein HH; Yi Q; Dore GJ; Krahn MD
AIDS; 2008 Oct; 22(15):1979-91. PubMed ID: 18784461
[TBL] [Abstract][Full Text] [Related]
2. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.
Thein HH; Yi Q; Dore GJ; Krahn MD
Hepatology; 2008 Aug; 48(2):418-31. PubMed ID: 18563841
[TBL] [Abstract][Full Text] [Related]
3. Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy.
Fuster D; Planas R; Muga R; Ballesteros AL; Santos J; Tor J; Sirera G; Guardiola H; Salas A; Cabré E; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1293-7. PubMed ID: 15650421
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
Macías J; Mira JA; López-Cortés LF; Santos I; Girón-González JA; González-Serrano M; Merino D; Hernández-Quero J; Rivero A; Merchante N; Trastoy M; Carrillo-Gómez R; Arizcorreta-Yarza A; Gómez-Mateos J; Pineda JA
Antivir Ther; 2006; 11(7):839-46. PubMed ID: 17302246
[TBL] [Abstract][Full Text] [Related]
5. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
6. Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine.
Macías J; Castellano V; Merchante N; Palacios RB; Mira JA; Sáez C; García-García JA; Lozano F; Gómez-Mateos JM; Pineda JA
AIDS; 2004 Mar; 18(5):767-74. PubMed ID: 15075511
[TBL] [Abstract][Full Text] [Related]
7. Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C virus-coinfected patients?
Verma S; Wang CH; Govindarajan S; Kanel G; Squires K; Bonacini M
Clin Infect Dis; 2006 Jan; 42(2):262-70. PubMed ID: 16355339
[TBL] [Abstract][Full Text] [Related]
8. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.
Smit C; van den Berg C; Geskus R; Berkhout B; Coutinho R; Prins M
J Acquir Immune Defic Syndr; 2008 Feb; 47(2):221-5. PubMed ID: 18223361
[TBL] [Abstract][Full Text] [Related]
9. Progression of liver fibrosis in monoinfected patients by hepatitis C virus and coinfected by HCV and human immunodeficiency virus.
Tovo CV; Becker SC; Almeida PR; Galperim B; Chaves S
Arq Gastroenterol; 2013; 50(1):19-22. PubMed ID: 23657302
[TBL] [Abstract][Full Text] [Related]
10. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.
Martinez-Sierra C; Arizcorreta A; Díaz F; Roldán R; Martín-Herrera L; Pérez-Guzmán E; Girón-González JA
Clin Infect Dis; 2003 Feb; 36(4):491-8. PubMed ID: 12567308
[TBL] [Abstract][Full Text] [Related]
11. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.
Aranzabal L; Casado JL; Moya J; Quereda C; Diz S; Moreno A; Moreno L; Antela A; Perez-Elias MJ; Dronda F; Marín A; Hernandez-Ranz F; Moreno A; Moreno S
Clin Infect Dis; 2005 Feb; 40(4):588-93. PubMed ID: 15712082
[TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.
de Lédinghen V; Barreiro P; Foucher J; Labarga P; Castéra L; Vispo ME; Bernard PH; Martin-Carbonero L; Neau D; García-Gascó P; Merrouche W; Soriano V
J Viral Hepat; 2008 Jun; 15(6):427-33. PubMed ID: 18221303
[TBL] [Abstract][Full Text] [Related]
13. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.
Pineda JA; García-García JA; Aguilar-Guisado M; Ríos-Villegas MJ; Ruiz-Morales J; Rivero A; del Valle J; Luque R; Rodríguez-Baño J; González-Serrano M; Camacho A; Macías J; Grilo I; Gómez-Mateos JM;
Hepatology; 2007 Sep; 46(3):622-30. PubMed ID: 17659577
[TBL] [Abstract][Full Text] [Related]
14. Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosis.
Lanternier F; Roulot D; Bentata M; Pol S; Viard JP; Gordien E; Jeantils V; Ziol M; Lortholary O
Gastroenterol Clin Biol; 2007 Oct; 31(10):822-7. PubMed ID: 18166860
[TBL] [Abstract][Full Text] [Related]
15. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.
Bräu N; Salvatore M; Ríos-Bedoya CF; Fernández-Carbia A; Paronetto F; Rodríguez-Orengo JF; Rodríguez-Torres M
J Hepatol; 2006 Jan; 44(1):47-55. PubMed ID: 16182404
[TBL] [Abstract][Full Text] [Related]
16. Levels of serum markers of liver inflammation and fibrosis in patients with chronic hepatitis C virus infection according to HIV status and antiretroviral use.
Connoy A; Turner J; Núñez M
AIDS Res Hum Retroviruses; 2011 Jul; 27(7):719-25. PubMed ID: 21128862
[TBL] [Abstract][Full Text] [Related]
17. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C
HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909
[TBL] [Abstract][Full Text] [Related]
18. Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients.
Mariné-Barjoan E; Saint-Paul MC; Pradier C; Chaillou S; Anty R; Michiels JF; Sattonnet C; Ouzan D; Dellamonica P; Tran A;
AIDS; 2004 Nov; 18(16):2163-70. PubMed ID: 15577649
[TBL] [Abstract][Full Text] [Related]
19. Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy.
Pineda JA; Macías J
J Antimicrob Chemother; 2005 Apr; 55(4):417-9. PubMed ID: 15731202
[TBL] [Abstract][Full Text] [Related]
20. Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels.
Pace FH; Ferreira LE; Silva AE; Ferraz ML
Rev Soc Bras Med Trop; 2012; 45(4):444-7. PubMed ID: 22930041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
